Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.
scientific article
Author/s
author: David Belada, Corinne Haioun, David Simpson, Sirpa Leppä, Pierre-Louis Soubeyran, René-Olivier Casasnovas, Gilles Salles, Luc Xerri, Pierre Feugier, Pauline Brice, Alain Delmer, Christophe Fermé, Catherine Sebban, Anne Sonet, Hervé Tilly, Bertrand Coiffier, John Vincent Catalano, Jane A Estell
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.